GENENTA SCIENCE S.P.A.
Olgettina No. 58
20132 Milan, Italy
May 22, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: | Cindy Polynice |
Re: | Genenta Science S.p.A. |
Registration Statement on Form F-3 (File No. 333-271901) filed May 12, 2023. |
Requested Date: May 24, 2023
Requested Time: 4:30 PM Eastern Time
Ladies and Gentlemen:
Genenta Science S.p.A. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form F-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission.
The Registrant hereby authorizes Per Chilstrom, who is an attorney with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Chilstrom at (212) 430-2669.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
Sincerely, | ||
Genenta Science S.p.A. | ||
By: | /s/ Pierluigi Paracchi | |
Pierluigi Paracchi | ||
Chief Executive Officer |
cc: | Richard B. Slansky, Chief Financial Officer |
Genenta Science S.p.A. | |
Per B. Chilstrom, Esq. | |
Fenwick & West LLP |